| Hans-Günter Meyer-Thompson | International
USA. DEA Pursues Vast Expansion of Patient Surveillance
USA. DEA Pursues Vast Expansion of Patient Surveillance
The Drug Enforcement Administration (DEA) is looking to expand its anti-diversion surveillance infrastructure by being able to search and analyze myriad patient behaviors for the vast majority of controlled and scheduled drug prescriptions—all accompanied by a rapid process for legally unveiling personally identifying information. (Filter, USA, 09.11.2020)